The GEO Group
This is the archived full research. Read the story
GEO runs immigration detention centres and electronic ankle-monitor programmes for the US government, mostly in buildings it owns.
The scores
Growth3/4 ↑
Revenue up 12% in Q3 2026 on new ICE beds and $365M of new contracts, but flat 2021 to 2024 and tied to one policy.
Business quality3/4 →
Existing permitted sites are scarce and DHS pays replacement prices for them, but ICE can end contracts and plans to own its sites.
Financial position3/4 ↑
Net debt under 3 times profit, the 2029 notes repaid, nothing due before 2031; the 10.25% notes are costly.
Execution record3/4 →
Guidance raised from $500M to $570M and beaten, first DHS sale closed, but Q4 2025 missed and Florida slipped a year.
Per share capture3/4 ↑
Buybacks cut diluted shares 6% and the authorization is $1.25B, but none was bought in Q3 and sale proceeds go first to tax and debt.
Potential2/4 →
Signed 2027 contracts are bounded; the large upside, a sale and 100,000 beds, rests on DHS decisions outside GEO's control.
Risk profile2/4 →
One agency is half of revenue on terminable contracts, and federal policy can turn in one election.
Valuation3/4 ↑
About 10.8 times operating profit before depreciation, 90% of a three-stage value near $35.62 at an 8% return: fair, inside the 20% margin.
Evidence quality3/4 →
Filings, the statute and TRAC's counts are solid and the first sale is in an 8-K, but further sales rest on management's words.
The Verdict
We rate GEO Neutral. It runs immigration detention centres and ankle-monitor programmes for the US government, mostly in buildings it owns, and holds about a third of the people detained. Contracts are strong and the last report beat its forecast, but one customer is half the business, politics can turn fast and detention has stopped growing, so the business is mixed. On 2 October it sold three centres to the government for $950M and keeps running them. The price sits a little under our value and counts on more sales: four more centres are readied for sale, none signed.
The long caseImmigration enforcement is holding far more people in detention; GEO gains only if that lasts and it signs the sale of jails the price already counts on.
How we weighed it
The price against our value
Cuts both ways
Price at 90% of our value
The price is about nine-tenths of our value, with the bear case well below.
The business
Cuts both ways
Mixed
Strong contracts, but resting on one customer and on politics.
Growth against what the price assumes
Cuts both ways
Four more centres are readied for sale, but none has an agreement, a price or a date.
What could go wrong
Against it
One customer is half the business, policy can reverse, detention has stopped growing and a sale shrinks its edge.
Against competitors
Cuts both ways
There is no listed rival to compare directly.
How its group is behaving
Cuts both ways
It sits in none of our ranked groups; federal policy moves it.
The latest news and report
In its favour
The filed quarter held the operating story and readied four more centres for sale; none is signed.
The evidence under this - 9 claims
TRAC's latest count we hold, 65,765 in detention on 2026-07-11, is below the 73,000 the chairman cites; his figure is not sourced on the call.
- 2026-11-11editedre-sourced to the Q3 call and 10-Q: the national count the chairman cites rose to about 73,000 and ICE beds under contract to about 33,000
ICE can end the contract for non-appropriation or convenience, and the 8-K says GEO can give no assurance that it will keep managing the sites; the 8-K does not say whether the fees under the contract change.
- The 8-K does not say whether fees under the support contract change now DHS owns the buildings, so profit forgone is unknown; CoreCivic's guidance fell about $15M on $2.2B of sales.
- The $705M is GEO's expectation after tax and fees, and the debt indentures take their share first.
- 2026-11-05editedre-struck at the 4 November close with the raised guide
- 2026-11-11editedre-struck at the 10 November close and set against the four centres the 10-Q classifies as held for sale
The vendor puts enterprise value at $5.72B on a higher share count; the filed count is used here.
- 2026-10-06editedre-struck at the 2026-10-05 close, $32.34, after the Adelanto sale
- 2026-11-05editedre-struck at the 4 November close on the Q3 balance sheet and trailing profit
- 2026-11-11editedre-struck at the 10 November close
In May the chairman guessed 'late Q2, maybe early Q3' for first sales; in August it became end of Q3, possibly Q4; on 5 November he called one or more sales before the end of the quarter a reasonable chance; one facility needs a separate appraisal.
- 2026-10-06editedthe first sale closed on 2026-10-02 (C55); what remains in process is the further sales, with no agreement or date
- 2026-11-05editedQ3 release repeats that no further sale has an agreement or timeline
- 2026-11-11editedthe Q3 10-Q repeats that no further sale has an agreement or timeline; the call's new timing added as counter-evidence
- 2026-11-05editedrefresh date rolled to the next vendor snapshot; the analyst split and short interest were not re-pulled in this review
Held for sale is GEO's own accounting judgement that a sale within a year is probable; the filing adds that it can give no assurance the transactions take place at all, and states no price.
The company
GEO houses, feeds, guards, transports and gives medical care to people held by Immigration and Customs Enforcement, the agency known as ICE, while their cases are decided. It also runs prisons for states and for Australia and South Africa, and halfway houses for people leaving prison.
ICE's alternative is to build its own centres or rent cells in county jails. Congress gave it $45B for detention in 2025, and GEO added about 6,000 ICE beds that year.
The evidence under this - 5 claims
The per-bed figure is the seller's average; the four prices range from $238.4M to $739.2M and DHS publishes none of them per bed.
- 2026-10-06editedGEO's own per-bed price, the DHS purchase the refresh trigger named, is now known
How it makes money
ICE pays GEO for each detainee each day, or a fixed monthly sum per centre. In its detention business GEO took in about $118 per person per day in Q2 2026. ICE alone paid 47.6% of 2025 revenue.
The smaller monitoring business charges ICE for each person on an ankle monitor or phone app. It is about a tenth of revenue but keeps about 41 cents of each dollar as profit, against about 22 cents in detention.
The evidence under this - 5 claims
Where the money comes from, stream by stream
| Stream | Share of sales (FY2025) | How it earns it |
|---|---|---|
| Owned and leased secure facilities | 52.8% | ICE, Marshals and state detainees housed in GEO's own buildings, paid per person per day or a fixed monthly sum. |
| Managed-only facilities | 24.4% | Staffing and running government-owned prisons and detention centres in the US, Australia and South Africa for a management fee. |
| Electronic monitoring and other reentry | 16.6% | BI's ankle monitors, phone app and casework for ICE's ISAP programme and state and county parole, paid per participant per day. |
| Owned and leased community reentry | 6.3% | Residential reentry centres for people leaving prison, run for federal and state agencies in buildings GEO owns or leases. |
Who runs it
George Zoley founded GEO in 1984 and took back the chief executive job in March 2026, after three others came and went in five years; a long-time insider, Shayn March, now runs the money. Insiders own about 5%, most of it Zoley's. The bonus rides on profit before interest and on sales; other officers' long-term shares ride on return on capital and the stock price, while Zoley's simply vest with time. Nothing pays on cash flow.
The evidence under this - 3 claims
Why it wins, and who could beat it
Why customers come back
What GEO has that is hard to copy is the building: a secure, approved site near where ICE arrests people. Towns fight new ones. ICE tried to buy warehouses to convert instead, and local opposition blocked at least 12.
The proof is the price. The government paid about $307,000 a bed for CoreCivic's centres, against $131,000 a bed that Oklahoma paid GEO for an ordinary state prison in 2025.
The evidence under this - 4 claims
The Lawton sale was a state prison bought by a state, not an ICE site, so the comparison mixes buyers; and ICE's owning the sites is itself the route by which this moat is bought out.
The per-bed figure is the seller's average; the four prices range from $238.4M to $739.2M and DHS publishes none of them per bed.
- 2026-10-06editedGEO's own per-bed price, the DHS purchase the refresh trigger named, is now known
The threat
The customer wants to own the buildings. ICE's own plan is to run mainly from sites it owns. If it buys GEO's centres, GEO gets cash but becomes an operator that ICE can later replace with CoreCivic or someone else at the next tender.
The evidence under this - 4 claims
ICE is re-procuring four GEO sites as long contracts before any sale, and the chairman says several sites already carry long support contracts, which would delay any re-bid.
The rivals: CXW, and 2 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| Not listed | U.S. Immigration and Customs Enforcement, through its Detention Reengineering Initiative of ICE-owned converted warehousesPriced against it: Not listed | U.S. Secure Services | Announced | Not listed |
| CXW | CoreCivicPriced against it: Same product | U.S. Secure Services | On sale | Same product |
| Private | Allied UniversalPriced against it: Private | Electronic Monitoring and Supervision Services | On sale | Private |
How big it could get
How big this could get
On 11 July 2026 ICE held 65,765 people. At GEO's rate of about $118 a day, that is roughly $2.8B a year of detention, and GEO had contracts for about 26,000 of those beds at the end of 2025.
Management says ICE wants about 100,000 beds. That figure is the company's; the count has not passed 70,766.
The evidence under this - 4 claims
A leaked July 2025 ICE plan aimed at 107,759 beds by the end of 2025; TRAC's count has not passed 70,766 and was 65,765 in July 2026.
Who has signed
ICE signed five-year contracts for two reopened centres, Big Horn and Rivers, worth about $165M a year from 2027, and a two-year monitoring contract. Florida signed two prisons worth about $100M from July 2027. Every government contract can be ended on months of notice.
The evidence under this - 3 claims
The Florida contracts already slipped a year on unresolved state budget issues, and the revenue figures are management's first-full-year estimates.
Where the growth is coming from, business by business
Where the growth is coming from
| Business | Share of revenue | Growth: last quarter | Last half-year | Last year | Share in 3 years at its half-year rate |
|---|---|---|---|---|---|
| Us Corrections And Detention | 71% | +12.5% | +15.1% | +18.3% | 72% |
| Electronic Monitoring And Supervision Services | 11% | +1.6% | -0.9% | -1.4% | 7% |
| Reentry Services | 10% | +2.3% | +1.9% | +2.2% | 7% |
| International Services Segment | 8% | +32.3% | +37.2% | +18.4% | 14% |
| Whole company | 100% | +11.5% | +13.2% | +14.0% | 100% |
On the filed split through 2026-09-30, if each business keeps its last half-year's growth, the company grows about 14% next year and 15% in year 3, against 15.3% over the last twelve months. A scenario, not a forecast: no business holds its rate.
The results
The numbers
Sales grew 15% over the twelve months to Sep 2026, faster than the 8.6% in the year to Dec 2025.
Operating margin is 13%, about where it was (15%) in the year to Dec 2023.
Yearly sales growth has ranged from −4.0% to +8.6% over the last 5 years, with sales falling in 1 of them.
Each dollar put into the business earns 8.6% a year after tax, about where it was (8.2%) in the year to Dec 2022.
It turned 7.5% of sales into free cash, $217M over the last twelve months.
It owes $1.31B more than the cash it holds, about 4.0 years of the cash its operations bring in.
The share count rose 9.3% in 4.8 years, and pay in shares costs 0.7% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $2.26B | $2.38B | $2.41B | $2.42B | $2.63B | $2.91B |
| Sales growth | −4.0% | +5.3% | +1.5% | +0.4% | +8.6% | +15% |
| Profit | ||||||
| Operating margin | 13% | 16% | 15% | 13% | 9.8% | 13% |
| Net margin | 3.4% | 7.2% | 4.4% | 1.3% | 9.7% | 5.7% |
| What growth costs, per sales dollar | ||||||
| General and admin | 9.1% | 8.3% | 7.9% | 8.8% | 9.0% | 8.9% |
| Pay in shares | 0.9% | 0.7% | 0.6% | 0.7% | 0.9% | 0.7% |
| Capital spending | 3.1% | 3.8% | 3.0% | 3.2% | 7.5% | 3.8% |
| Cash | ||||||
| Cash from operations | $283M | $288M | $278M | $242M | $72.6M | $328M |
| Free cash flow | $213M | $198M | $205M | $164M | −$125M | $217M |
| Balance sheet | ||||||
| Cash and short-term investments | $506M | $95.1M | $94.0M | $76.9M | $69.0M | $216M |
| Debt | $2.64B | $1.98B | $1.78B | $1.71B | $1.65B | $1.53B |
| Net cash | −$2.14B | −$1.88B | −$1.69B | −$1.64B | −$1.58B | −$1.31B |
| Returns and shares | ||||||
| Return on capital | - | 8.2% | 8.4% | 7.7% | 6.2% | 8.6% |
| Shares (diluted) | 121M | 122M | 124M | 134M | 140M | 132M |
What growth costs
Growth costs GEO almost as much as it brings in: every new bed needs guards, food and medical care, and the fast-growing part has been detention while the more profitable monitoring business shrank. So profit margins narrowed from 2022 to 2025, and only began to widen again in 2026 as new contracts filled.
The evidence under this - 2 claims
- In the first half of 2026 operating expenses fell to 73.2 cents per sales dollar from 74.9 a year earlier and operating margin rose to 13.3% from 10.7%, as newly activated ICE contracts filled (S02).
- 2025's capital spending included reopening idle sites for ICE, a one-off rather than a cost that grows with sales (C23).
The last report (5 Nov)
Quarter ended September 2026, filed figures.
Q3 2026 revenue rose 12% to $761.1M and profit before interest, tax and depreciation rose 21% to a record $145.3M, at the top of GEO's own range. GEO raised its 2026 forecast to $568M-$573M and repaid its $650M of 2029 notes with the Adelanto sale money.
Two ICE centres started, Tacoma was renewed for 10 years and Big Spring begins on 1 November. The buyback total did not move from June. GEO again said there is no agreement or date for selling more centres, but its 10-Q shows four more, 5,919 beds, readied for sale in October.
What it did to the thesisThe operating story held and debt fell. Four more centres are readied for sale but none is signed, so the view stays Neutral.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $0.39 against $0.35 expected.
The evidence under this - 7 claims
The August guide assumes smaller labour-cost savings in the second half and excludes Big Horn, Rivers and the Florida contracts; Q4 2025 earnings of $0.25 a share missed the $0.27 expected.
- 2026-11-05editedQ3 release raised the 2026 guidance a third time
- 2026-10-10editedthe 8-K of 2026-10-08 gives the size, price and date of the 2029 redemption and the new revolver maturity; the June-30 balances are otherwise unchanged until the Q3 10-Q
- 2026-11-05editedQ3 balance sheet; the 2029 notes were redeemed on 15 October
- 2026-11-05editedQ3 release gives the program total to 5 November, unchanged since June
In May the chairman guessed 'late Q2, maybe early Q3' for first sales; in August it became end of Q3, possibly Q4; on 5 November he called one or more sales before the end of the quarter a reasonable chance; one facility needs a separate appraisal.
- 2026-10-06editedthe first sale closed on 2026-10-02 (C55); what remains in process is the further sales, with no agreement or date
- 2026-11-05editedQ3 release repeats that no further sale has an agreement or timeline
- 2026-11-11editedthe Q3 10-Q repeats that no further sale has an agreement or timeline; the call's new timing added as counter-evidence
Held for sale is GEO's own accounting judgement that a sale within a year is probable; the filing adds that it can give no assurance the transactions take place at all, and states no price.
What management did with the money
Management spent about $177M buying back 10.1M shares since August 2025, cutting the share count by about 6%, and has bought none since June although it calls buybacks a paramount priority. It repaid its $650M of 2029 notes with Adelanto's proceeds, leaving $625M of debt due in 2031 and about $600M of available cash and credit.
Insiders in 2026Q2: 2 purchases and 0 sales, from their Form 4 filings.
The evidence under this - 3 claims
- 2026-11-05editedQ3 release gives the program total to 5 November, unchanged since June
- 2026-10-10editedthe 8-K of 2026-10-08 gives the size, price and date of the 2029 redemption and the new revolver maturity; the June-30 balances are otherwise unchanged until the Q3 10-Q
- 2026-11-05editedQ3 balance sheet; the 2029 notes were redeemed on 15 October
The authorization does not oblige GEO to buy any shares, and the CFO has said proceeds must first satisfy the indenture and credit-agreement terms.
- 2026-10-10editedthe 8-K of 2026-10-08 shows the new credit agreement's buyback test; the proceeds' use still has no stated split beyond the 2029 redemption
The price, and where we disagree
In short. Fair. The price is about 90% of what we think the business is worth, at an 8% yearly return.
In July and August 2026 the government bought four of CoreCivic's jails for $2.2B. On 2 October it bought three of GEO's in Adelanto, California, for $950M. The shares fell to $27.53 on 4 November and closed at $31.94 on 10 November, while GEO's profit forecast rose.
GEO's report and 10-Q still name no agreement or date for more sales, but the 10-Q shows four more centres, 5,919 beds, readied for sale in October. One county extended a GEO centre's agreement by only six months. The next test is the Q4 report, expected around the end of February 2027.
The evidence under this - 8 claims
ICE can end the contract for non-appropriation or convenience, and the 8-K says GEO can give no assurance that it will keep managing the sites; the 8-K does not say whether the fees under the contract change.
In May the chairman guessed 'late Q2, maybe early Q3' for first sales; in August it became end of Q3, possibly Q4; on 5 November he called one or more sales before the end of the quarter a reasonable chance; one facility needs a separate appraisal.
- 2026-10-06editedthe first sale closed on 2026-10-02 (C55); what remains in process is the further sales, with no agreement or date
- 2026-11-05editedQ3 release repeats that no further sale has an agreement or timeline
- 2026-11-11editedthe Q3 10-Q repeats that no further sale has an agreement or timeline; the call's new timing added as counter-evidence
- 2026-10-06editedthe 8-K that the claim said had not been filed was filed on 2026-10-05
- 2026-11-05editedrefresh date rolled: the Q3 release does not mention Moshannon Valley, so the March 2027 extension stands as filed; not independently re-checked today
- 2026-10-06editedre-struck at the 2026-10-05 close after the Adelanto sale
- 2026-11-05editedre-struck at the 4 November close
- 2026-11-11editedre-struck at the 10 November close
Held for sale is GEO's own accounting judgement that a sale within a year is probable; the filing adds that it can give no assurance the transactions take place at all, and states no price.
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 6%, 4.3% | 12.1%, 8.5% | 15.1%, 10.6% |
| Normal operating margin | 11.2% | 14.1% | 15.5% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $16.22 | $35.62 | $48.06 |
- Price
- $31.94
- Priced on
- 10 Nov
- Price as a share of the base value
- 90%
- Starting growth the price pays for
- 6.1%
- Yearly return the price offers on the base case
- 8.3%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $19.22
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Tax rate | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 31 Dec 2025, filed 25 Feb 2026: the year's sales over its operating capital. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026, 31 Dec 2027 and 31 Dec 2028: the average of 1 to 3 analysts' revenue estimates, 12.1%, 8.5%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2028, the average of one analyst's estimates, 18.6%, less stock pay of 0.8% of sales and less the 3.8% the analysts add back on their adjusted basis. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 10 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 6% and 4%, the margin settles a fifth lower at 11.2%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows 12% and 9% over two years, the analysts' path raised after the Q3 print (C60), then fades toward 4%, closing 30% of the gap each year; the margin moves to 14.1%, the analysts' year-three figure after stock pay and on the filed basis (3.9% less).
Bull caseGrowth runs a quarter above the analysts' path, 15% and 11%, the margin reaches 15.5%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $33.30 | $38.10 |
| The normal margin, 15% lower or higher | $28.19 | $43.04 |
| Capital per dollar of growth, a quarter more or less | $32.82 | $37.29 |
| Return on new capital after year ten, at the rate or one step up | $25.96 | $39.48 |
| The rate, a point higher or lower | $25.76 | $52.10 |
| Long-run growth a point lower | $30.91 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 11.3% | $22.79 | $24.20 | $25.72 | $27.34 | $29.08 |
| 12.7% | $26.96 | $28.75 | $30.67 | $32.72 | $34.91 |
| 14.1% | $31.14 | $33.30 | $35.62 | $38.10 | $40.74 |
| 15.5% | $35.32 | $37.85 | $40.57 | $43.47 | $46.58 |
| 16.9% | $39.50 | $42.40 | $45.52 | $48.85 | $52.41 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
Counting debt, a buyer pays about 10 times the cash profit, before interest and tax, that GEO forecasts for this year, against about 7 times usually; about 8.5 times once Adelanto's $705M is set against debt.
At 7 times, the business alone is worth about $20 a share. The rest of the price is roughly what selling 5,800 beds to the government would bring after tax at Adelanto's price. Adelanto covers about 46%; about 3,100 more beds are not agreed, fewer than GEO has readied for sale.
Against its own history. Buyers are paying well above GEO's own normal, which it has earned only while federal detention policy runs its way.
The evidence under this - 6 claims
The vendor puts enterprise value at $5.72B on a higher share count; the filed count is used here.
- 2026-10-06editedre-struck at the 2026-10-05 close, $32.34, after the Adelanto sale
- 2026-11-05editedre-struck at the 4 November close on the Q3 balance sheet and trailing profit
- 2026-11-11editedre-struck at the 10 November close
- The gap could instead be paying for 2027 growth: Big Horn, Rivers and Florida add about $265M of signed revenue, which at a segment margin near 22% is roughly $55M of profit, worth about $0.4B at 7 times, not $1.7B.
- GEO's tax basis in its buildings is not disclosed per site, so its tax on a sale could differ from CoreCivic's 26%.
- 2026-10-06editedre-struck at the 2026-10-05 close and the first sale's proceeds set against the gap
- 2026-11-05editedre-struck at the 4 November close with the raised guide
- 2026-11-11editedre-struck at the 10 November close: the price rose 16%, so Adelanto covers less of the gap
- The 8-K does not say whether fees under the support contract change now DHS owns the buildings, so profit forgone is unknown; CoreCivic's guidance fell about $15M on $2.2B of sales.
- The $705M is GEO's expectation after tax and fees, and the debt indentures take their share first.
- 2026-11-05editedre-struck at the 4 November close with the raised guide
- 2026-11-11editedre-struck at the 10 November close and set against the four centres the 10-Q classifies as held for sale
- The contracts at the four sites have not been re-priced yet; if DHS strips out the building's return from the per diem, the lost profit could be several times $15M.
- About 26% of CoreCivic's gross proceeds went in tax, which a per-bed headline hides.
The August guide assumes smaller labour-cost savings in the second half and excludes Big Horn, Rivers and the Florida contracts; Q4 2025 earnings of $0.25 a share missed the $0.27 expected.
- 2026-11-05editedQ3 release raised the 2026 guidance a third time
Held for sale is GEO's own accounting judgement that a sale within a year is probable; the filing adds that it can give no assurance the transactions take place at all, and states no price.
Priced against its rivals
Only CoreCivic sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Private or foreign rivals that cannot be priced: Management and Training Corporation, LaSalle Corrections, Allied Universal, Sodexo Justice Services, Serco.
Where we disagree with the market
The market sees GEO as the main winner of mass detention, with more jail sales to the government as near-certain extra value.
We think sales add value and one has closed, but most of what the price counts on is unagreed, and each sale turns GEO into an operator ICE can replace.
This stock has swung by half its value on detention politics before: it jumped 42% on the 2024 election, then fell 62% during its best year of contract wins. The price follows headlines, and the headline now is jail sales.
We could be wrong. A second signed sale that takes the total to 5,000 beds or more near $300,000 each, with GEO still running them, or detention passing 75,000, would make the price look cheap.
What analysts say, and the evidence
The evidence under this - 9 claims
- 2026-11-05editedrefresh date rolled to the next vendor snapshot; the analyst split and short interest were not re-pulled in this review
- The gap could instead be paying for 2027 growth: Big Horn, Rivers and Florida add about $265M of signed revenue, which at a segment margin near 22% is roughly $55M of profit, worth about $0.4B at 7 times, not $1.7B.
- GEO's tax basis in its buildings is not disclosed per site, so its tax on a sale could differ from CoreCivic's 26%.
- 2026-10-06editedre-struck at the 2026-10-05 close and the first sale's proceeds set against the gap
- 2026-11-05editedre-struck at the 4 November close with the raised guide
- 2026-11-11editedre-struck at the 10 November close: the price rose 16%, so Adelanto covers less of the gap
- The 8-K does not say whether fees under the support contract change now DHS owns the buildings, so profit forgone is unknown; CoreCivic's guidance fell about $15M on $2.2B of sales.
- The $705M is GEO's expectation after tax and fees, and the debt indentures take their share first.
- 2026-11-05editedre-struck at the 4 November close with the raised guide
- 2026-11-11editedre-struck at the 10 November close and set against the four centres the 10-Q classifies as held for sale
In May the chairman guessed 'late Q2, maybe early Q3' for first sales; in August it became end of Q3, possibly Q4; on 5 November he called one or more sales before the end of the quarter a reasonable chance; one facility needs a separate appraisal.
- 2026-10-06editedthe first sale closed on 2026-10-02 (C55); what remains in process is the further sales, with no agreement or date
- 2026-11-05editedQ3 release repeats that no further sale has an agreement or timeline
- 2026-11-11editedthe Q3 10-Q repeats that no further sale has an agreement or timeline; the call's new timing added as counter-evidence
- 2026-10-06editedthe 8-K that the claim said had not been filed was filed on 2026-10-05
- 2026-11-05editedrefresh date rolled: the Q3 release does not mention Moshannon Valley, so the March 2027 extension stands as filed; not independently re-checked today
ICE is re-procuring four GEO sites as long contracts before any sale, and the chairman says several sites already carry long support contracts, which would delay any re-bid.
The 2025 fall also tracked real disappointment: ISAP participants fell and its contract was repriced, and 2025 Adjusted EBITDA was flat at $464.4M against $463.5M.
What could go wrong, and how we would know
The risks
- One customer is half the business. ICE paid 47.6% of 2025 revenue, and its contracts can be ended on 30 to 180 days' notice.
- Politics can turn fast. A future president could restrict private detention, as a 2021 order did for Justice Department prison contracts.
- Detention has stopped growing. ICE held 70,766 people in January 2026 and 65,765 in July, far short of the 100,000 management talks about.
- A sale shrinks the moat. Once ICE owns a building, the running contract can be put out to tender, and GEO's advantage becomes a contract rather than a site.
- Detainee wage lawsuits. Washington courts ordered $37.6M paid to detainees who worked in a GEO centre; similar suits in California and Colorado wait on the Supreme Court.
The evidence under this - 6 claims
ICE is re-procuring four GEO sites as long contracts before any sale, and the chairman says several sites already carry long support contracts, which would delay any re-bid.
What we still do not know
- How GEO's running fees at Adelanto change now the government owns the buildings, and what price further sales would get.
- How much of a sale would go in tax. GEO does not disclose what its buildings cost it, site by site.
- Whether detention resumes growing toward 100,000 or has levelled off near 65,000.
- Whether the Supreme Court takes GEO's appeal on detainee wages.
The evidence under this - 6 claims
In May the chairman guessed 'late Q2, maybe early Q3' for first sales; in August it became end of Q3, possibly Q4; on 5 November he called one or more sales before the end of the quarter a reasonable chance; one facility needs a separate appraisal.
- 2026-10-06editedthe first sale closed on 2026-10-02 (C55); what remains in process is the further sales, with no agreement or date
- 2026-11-05editedQ3 release repeats that no further sale has an agreement or timeline
- 2026-11-11editedthe Q3 10-Q repeats that no further sale has an agreement or timeline; the call's new timing added as counter-evidence
The per-bed figure is the seller's average; the four prices range from $238.4M to $739.2M and DHS publishes none of them per bed.
- 2026-10-06editedGEO's own per-bed price, the DHS purchase the refresh trigger named, is now known
- The contracts at the four sites have not been re-priced yet; if DHS strips out the building's return from the per diem, the lost profit could be several times $15M.
- About 26% of CoreCivic's gross proceeds went in tax, which a per-bed headline hides.
ICE can end the contract for non-appropriation or convenience, and the 8-K says GEO can give no assurance that it will keep managing the sites; the 8-K does not say whether the fees under the contract change.
What would change our view
- Neutral→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $28.50, 80% of what we think the business is worth.about ≈$29.28 today, 6% below the last close
- Neutral→UnattractiveThe price runs 20% above fair value
It needs:
- ○The share price rises to about $42.74, 20% above what we think the business is worth.about ≈$40.22 today, 29% above the last close
- Neutral→UnattractiveDemand turns or the sale breaks
It needs any of:
- ○The number of people in ICE detention falls below 60,000.checked at the next results, due by 26 Feb
- ○GEO says talks to sell more centres to the government have ended without a deal.watched as it happens
We would also be wrong if
- ICE ends or does not renew the contract at any centre GEO owns.
- GEO's forecast for 2027 cash profit before interest and tax, due February 2027, is below $600M.
What is coming
- 5 November 2026 Q3 2026 results: Adjusted EBITDA against the $140M-$145M guide, Adelanto's effect on profit and debt, and whether a further DHS sale is signed with GEO operating it.
Every dated event ahead
- 5 November 2026 Q3 2026 results: Adjusted EBITDA against the $140M-$145M guide, Adelanto's effect on profit and debt, and whether a further DHS sale is signed with GEO operating it.
- 31 December 2026 44 contracts reach their renewal date: Whether ICE renews or re-bids the sites it uses, about a tenth of revenue; a lost re-bid would test the moat that rests on owning the building.
- March 2027 Moshannon Valley county agreement expires: Whether local opposition can close a large ICE site GEO already runs, the main threat to the permitted-site advantage.
- 1 July 2027 Florida's Graceville and Bay facilities start: Whether the about $100M of state contracts that slipped a year start on the new date, a check on execution after two delays.
Since we wrote this
- 11 NovPrice moveStill Neutral: four more centres readied for sale, none signedThe shares rose 16% and the filed quarter shows four more owned centres readied for sale. Analysts raised their forecasts, so our value rose too; the price is about 90% of it.
- 9 NovThesis reviewStill Neutral: priced at 94% of a value near $29.67Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits inside the 20% margin of safety.
- 5 NovEarningsRecord profit and a higher forecast; no second sale signedQ3 profit before interest, tax and depreciation was $145.3M, the top of the range. GEO still has no agreement for more sales, so Neutral holds.
- 2 NovNewsGEO announces a Big Spring, Texas contract for 2,329 beds; terms not readable. View heldGEO announces a contract for the Big Spring complex in Texas, 2,329 beds.
- 30 OctNewsGEO has a new management contract for its 1,635-bed Tacoma ICE centre. View heldGEO announces a new management contract for its Tacoma ICE centre.
- 19 OctNewsGEO finished repaying its 2029 secured notes, as it said it would. View heldGEO completes redemption of its 2029 secured notes.
- 10 OctNews2029 notes to be repaid for about $678M from sale proceedsGEO will redeem its 8.625% notes on 15 October with Adelanto money and extended its credit line to 2031. It is debt repayment, not new value, so the view stays Neutral.
- 6 OctNewsFirst DHS sale closed: Adelanto, $950M, about $359,300 a bedGEO sold 2,644 beds to DHS and keeps running them. It covers about 38% of what the price pays beyond the business; further sales have no agreement, so the view stays Neutral.
- 5 OctThesis reviewThe long case now sits under the verdictAfter the five-name pilot, the owner asked for the long case on every thesis.
- 4 OctThesis reviewOwner's checklist: revenue streams, cost of growth, management, catalystsThe owner's checklist found the method silent on who runs the company, what growth costs, where the money comes from and what is dated ahead; this pass fills those four blocks from the proxy and filings.
- 27 SepThesis writtenNeutral, medium convictionWritten five weeks before Q3 2026 results, after CoreCivic's four sales to DHS and with GEO's own sale still unsigned.
Also checked 2 times with nothing new to act on.
Sources 33
Sources - 33
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-02-25Item 1 business, contract developments, the facility table, idle beds, competition, customer concentration, contract terms, re-bids and renewals, and the risk factors on policybacksC02C03C11C17C22C28C36C41C45C48C49C53
- S02primarycompany filing2026-08-06segment revenue and operating income, compensated mandays and occupancy, the MD&A on ISAP, debt note, cash flow, share count and the litigation notebacksC01C06C07C11C24C25C26C27C28
- S03primarycompany release2026-08-06Q2 figures, the raised 2026 guidance, Q3 and Q4 guidance, the Big Horn and Rivers contracts, the Florida delay, the balance sheet and buybacksbacksC06C09C10C23C24C25
- S04primarytranscript2026-08-06GEO Q2 2026 earnings call transcriptmanagement on ICE census, the 100,000-bed aim, the DHS purchase process, ISAP mix and skip tracing; questions from Noble, Northland and Raymond James analysts
Our current census across our active ice facilities is approximately 24 thousand representing more than 1/3 of the current national ICE population of approximately 68 thousand. ... they may be trying to activate maybe 2 or 3. That would be maybe 5 thousand beds. ... focus within the agency and throughout the agency is to try to stand up approximately 100 thousand beds. ... I believe ICE has maybe $36 billion left for the buildup and of new facilities.
backsC14C20C22C23C39 - S05primarycompany release2026-02-122025 revenue, Adjusted EBITDA and the Lawton gain, the initial 2026 guidance, ICE capacity rising from about 20,000 to about 26,000 bedsbacksC09C32C43
- S06primarytranscript2026-05-06GEO Q1 2026 earnings call transcriptmanagement's first account of the DHS purchase plan, the paused warehouse project, the 50,000 owned beds and its timing guess for the first sales
At this time, the warehouse project has been paused, and DHS is evaluating how to proceed with this initiative to increase and consolidate detention capacity. ... including 50,000 owned beds at 70 facilities
backsC39 - S07primarycompany filing2026-08-06the four facility sales to DHS, each price, the taxes and the net proceeds, and that CoreCivic keeps managing thembacksC16
- S08primarytranscript2026-08-06CoreCivic Q2 2026 earnings call transcript CXWthe $307,000 average price per bed, the lowered 2026 Adjusted EBITDA guidance after the sales, and lower ICE populations in Q2 2026
we estimate our net proceeds from these 4 sales to be approximately $1.6 billion At an average price per bed of $307 thousand and considering the location, size, cost, time, and effort to replace these facilities
backsC17C18 - S09secondaryindustry data2026-09-27the national detention count and the alternatives-to-detention count, compiled from ICE's own releases by a university-founded research group
Immigration and Customs Enforcement held 65,765 in ICE detention according to data current as of July 11, 2026 . ... ICE Alternatives to Detention (ATD) programs are currently monitoring 183,181 families and single individuals, according to data current as of July 11, 2026
backsC12C13 - S10secondaryindustry data2026-09-27the detention count every two to twelve weeks since 2019, so the trend and the plateau since January 2026 are measured rather than asserted
{"date":"07/11/2026","ice_all":58231,"cbp_all":7534,"total_all":65765 ... {"date":"04/04/2026","ice_all":51428,"cbp_all":8883,"total_all":60311 ... {"date":"01/25/2026","ice_all":59644,"cbp_all":11122,"total_all":70766 ... {"date":"07/13/2025","ice_all":41349,"cbp_all":15467,"total_all":56816 ... {"date":"01/26/2025","ice_all":14882,"cbp_all":24356,"total_all":39238
backsC13 - S11secondaryindustry data2026-09-27the count on ankle monitors against the phone app, by field office; the national ankle-monitor totals, 53,192 on 2026-07-11 and 24,566 on 2025-07-12, are summed across field offices here, which corroborates GEO's account of the ISAP mix from outside the company
{"aor":"","atd_technology":"Total","count_num":183181,"alip_num":" 788.5","download_date":"07/11/2026","family_unit":"All"} ... {"aor":"Atlanta","atd_technology":"Ankle Monitor","count_num":4080,"alip_num":" 616.4","download_date":"07/11/2026","family_unit":"All"}
backsC12 - S12primarygovernment data2026-09-27the enacted size and expiry of the detention money, from the statute rather than from GEO's account of it
there is appropriated to U.S. Immigration and Customs Enforcement for fiscal year 2025, out of any money in the Treasury not otherwise appropriated, to remain available until September 30, 2029, $45,000,000,000, for single adult alien detention capacity and family residential center capacity.
backsC15 - S13secondaryother2026-09-27American Immigration Council, 'ICE's Warehouse Purchases Herald New Model for Immigration Detention' American Immigration CouncilICE's Detention Reengineering Initiative as released by the New Hampshire government: 16 warehouse processing centres, 8 large warehouses, 10 turnkey purchases; ICE owned 10 of about 220 sites in February 2025; 9 warehouses bought, at least 12 purchases blocked
ICE plans to do away with the decades of somewhat inefficient acquisition of contract detention capacity in pre-existing jails and prisons and instead replace the current system with a new one, under which ICE primarily operates out of 34 facilitiesthat it owns outright ... As of February 2025, ICE owned just 10 facilities out of the 220 which are currently being used to detain immigrants. ... ICE has already spent over $700 million to purchase 9 out of 24warehouses they intend to refurbish for this new project. ... Local advocacy and outrage has successfully blocked the purchase of at least 12 more
backsC38 - S14secondarynews2026-09-23Philadelphia Inquirer, 'GEO Group wins extended contract for Moshannon Valley detention center' Philadelphia InquirerClearfield County's 2-1 vote extending the Moshannon Valley agreement to mid-March 2027, and local reporting of a possible sale
There are signs the Moshannon Valley Processing Center could end up being sold to the federal government.
backsC21 - S15secondaryvendor data2026-09-27Research pack, frozen 2026-09-27 (FMP market data, FINRA short interest)close of $31.22 on 2026-09-25, the 52-week range, the price-move decomposition, the analyst split, short interest, the vendor's EV/EBITDA history and the EPS estimatesbacksC10C28C29C33C34
- S16primarycompany filing2026-09-27GEO insider Form 4 filings read by insider_fetch.py, 2025-09 to 2026-09no open-market purchases; five open-market sales of 38,930 shares, four of them discretionary, at $30 to $32 in August and September 2026backsC47
- S17tertiarynews2026-02-12Investing.com, 'GEO Group Q4 2025 slides: revenue growth overshadowed by EPS miss, stock tumbles' Investing.comthe stated objection on 2026-02-12: a $0.25 EPS against $0.27 expected, and 2026 guidance below 2025's gain-inflated $1.82backsC34
- S18primarycompany filing2026-02-20CoreCivic's description of the same business, its 71,884 beds at 77% occupancy, and its competition sectionbacksC37
- S19primarycompany filing2026-09-27no 8-K since the Q2 results on 2026-08-06; only Forms 4, 144 and 13GbacksC21
- S20primarycompany filing2026-03-19executive officers and their start dates, beneficial ownership at March 6, 2026, the 2025 bonus metrics and payouts, the performance-stock design, the special award to the chairman, and the pay-versus-performance table naming each chief executive since 2021backsC50C51C52C53
- S21primarycompany filing2026-10-04GEO XBRL company facts, FY2020 to the four quarters to June 2026, frozen as content/GEO/financials.jsoncontent/GEO/financials.jsonrevenue, general and administrative, share pay, capital spending, operating income, long-term debt and diluted share counts per year; GEO tags no research, selling or cost-of-revenue linebacksC49C53
- S22secondaryvendor data2026-10-04Earnings calendar saved by the daily routine, content/calendar/2026-10-04.json (FMP earnings, per symbol)content/calendar/2026-10-04.jsonthe next results date, 5 November 2026
"GEO": {"archived": false, "next": {"date": "2026-11-05"
backsC54 - S23primarycompany filing2026-10-05the sale of the Adelanto West, Adelanto East and Desert View facilities to DHS for $950,000,000 completed 2026-10-02, about $705M of expected net proceeds, the existing ICE contract's term to 2034-12-19, the buyback authorization raised from $500M to $1.25B, and that no definitive agreement exists for any further salebacksC17C20C21C31C55C56
- S24primarycompany filing2026-10-05the bed counts of the three facilities (1,280, 660 and 704), the use of proceeds (reduce debt, repurchase shares, general purposes), the authorization effective through 2029-12-31, and the chairman's statement on continuing to operate under the ICE contractsbacksC55C56
- S25secondaryvendor data2026-10-06FMP end-of-day closes for GEO via research.eod_bars, read 2026-10-06content/GEO/updates/2026-10-06-news.jsonthe 2026-10-05 close of $32.34 and the 52-week intraday high of $33.20
{'time': '2026-10-05', 'open': 32.9, 'high': 33.2, 'low': 31.67, 'close': 32.34}
backsC29C30C31 - S26primarycompany filing2026-10-08notice to redeem all $650.0M of 8.625% senior secured notes due 2029 at $1,043.13 per $1,000 (about $678M) on 2026-10-15, funded from the net proceeds of the recent asset sales; the revolver kept at $550.0M and extended to 2031-07-14; unlimited restricted payments, including buybacks, while pro forma total leverage is 2.25 times or lessbacksC24C56
- S27primarycompany filing2026-11-05Q3 revenue, net income and Adjusted EBITDA, the raised 2026 guidance, the new ICE contracts, the redemption of the 2029 notes, the 30 September balance sheet, the buyback total and the statement that no further sale has a definitive agreementbacksC09C20C24C25C30C31C54C58C59
- S28secondaryvendor data2026-11-05FMP end-of-day closes for GEO via thesis_delta, read 2026-11-05content/GEO/updates/2026-11-05-earnings.jsonthe 2026-11-04 close of $27.53
27.53 (2026-11-04)
backsC29C30C31 - S29primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC61
- S30secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closeread, but no claim rests on it
- S31primarycompany filing2026-11-06Note 15 subsequent events (Adelanto gain of about $560M net of $207M tax, the redemption, the Tacoma and Big Spring contracts), the four further centres classified as held for sale in October and their carrying values, the statement that no definitive agreement exists for further sales, and the monitoring revenue bridgebacksC05C20C44C54C57C62
- S32primarytranscript2026-11-05GEO 2026Q3 earnings call transcript (FMP), held 2026-11-05data/cache/transcripts/GEO-2026Q3the ICE census and national count, ICE beds under contract after the reactivations, the ISAP and ankle-monitor counts, and the chairman's timing for further sales
The current census across our active ICE facilities is approximately 24 thousand representing approximately 1/3 of the current national ICE population of approximately 73 thousand. ... The current overall ISAP count is approximately 190 thousand participants up from 184 thousand participants 3 months ago. The number is 58 thousand currently, from 17 thousand early in 2025. ... we are reasonably optimistic as I say that 1 or multiple facilities could be purchased by ICE from our company before the end of this quarter.
backsC05C20C44C54 - S33secondaryvendor data2026-11-11the 10 November close and the analysts' average revenue and operating profit for fiscal 2026 to 2028
close 31.94 (2026-11-10); revenueAvg 2026 2,991,436,000, 2027 3,351,479,600, 2028 3,597,585,500; ebitAvg 2028 671,435,830 (1 analyst)
backsC29C30C31C57C60C61